Mundipharma A/S: Financial statements 2025
CVR: 17981994
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Mundipharma A/S (CVR 17981994) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. That is a decrease of 2% compared with the year before. The profit margin was 2.6%. Equity in the 2025 report amounted to DKK 38,165,000. The solvency ratio was 74.3%. The company had 3 employees in the financial year.
- Revenue
- DKK 25,912,000
- Gross Profit
- DKK 4,352,000
- Profit/Loss
- DKK 672,000
- Equity
- DKK 38,165,000
- Total Assets
- DKK 51,353,000
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 25.9M | 4.4M | 672K | 38.2M | 3 |
| 2024 | 26.4M | 3.1M | 514K | 37.5M | 2 |
| 2023 | 35.9M | 3.1M | 897K | 37M | 2 |
| 2022 | 40.1M | 6.8M | 709K | 49.8M | 4 |
| 2021 | 48.5M | 10.5M | 910K | 49.1M | 9 |
Official annual report
How creditworthy is Mundipharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of November 28, 2025, Elliot James Haddock has joined the board of directors of Mundipharma A/S.
As of November 28, 2025, Sarah Anna Heidrich has left the board of directors of Mundipharma A/S.
Mundipharma A/S has won the tender "Amgros 2026 1.607.a" issued by Amgros I/S worth 60,481,552 DKK.
Mundipharma A/S has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.
Mundipharma A/S has won the tender "Amgros 2026 2.690.b" issued by Amgros I/S worth 217,081,515 DKK.
Mundipharma A/S has published its annual report for 2024. Revenue came to DKK 26,430,000, and the net result was DKK 514,000.
As of March 7, 2025, Stephen Johan Jamieson has joined the board of directors of Mundipharma A/S.
As of March 7, 2025, Sarah Anna Heidrich has joined the board of directors of Mundipharma A/S.
As of March 7, 2025, Jörg Fischer has left the board of directors of Mundipharma A/S.
As of March 6, 2025, Stephen Johan Jamieson has left the board of directors of Mundipharma A/S.
About Mundipharma A/S
Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.
